Novitium Labs Private Limited
About Novitium Labs Private Limited
Data last updated:
Novitium Labs Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Novitium Pharma Llc. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2016PTC112516. Its GSTIN is 33AAFCN3546C1ZU (Tamil Nadu).
The company has an authorised share capital of ₹3.25 Cr and a paid-up capital of ₹3.25 Cr. It is led by directors Ayyavu Rajavel and Shanmugam Muthusamy.
Its last annual general meeting (AGM) was held on 15 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.8 Cr, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹3.36 Cr (net margin 9.9%) and EBITDA of ₹7.84 Cr (EBITDA margin 23.2%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years and 43% over five years.
The company has about 163 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5 Lakh on record. Court records list 1 case involving the company, including 1 filed against it. The company has 2 deals on record (2 rights issues); the latest was in March 2017. The company has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Novitium Labs Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressModule No.20 21 22 23 38&39 2nd Floor SIDCO Complex SIDCO Industrial Estate Thirumaz, Hisai, Chennai, Tamil Nadu, India – 600124
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novitium Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novitium Labs is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Novitium Labs Private Limited, buy the company report.
Financials of Novitium Labs Private Limited
FY 2025 filings availableNovitium Labs Private Limited reported revenue of ₹33.8 Cr (up 58% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 58% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.84 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.36 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.2% | ||||
| Net Profit Margin | 9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novitium Labs Private Limited, buy the company report.
Board of directors of Novitium Labs Private Limited
Novitium Labs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayyavu Rajavel Also directs: Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited, Esjay Pharma Private Limited and 5 more | Director | 15 Sep 2016 | 10 Years 1 Months | Current |
| Shanmugam Muthusamy Also directs: Annamar Pharma LLP, Nuray Chemicals Private Limited, Saimirra Innopharm Private Limited and 5 more | Director | 15 Sep 2016 | 10 Years 1 Months | Current |
Auditor
Novitium Labs Private Limited is audited by SENTHIL RAJA & MEHALA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SENTHIL RAJA & MEHALA | FY 2022 | 012995S |
Shareholding
The shareholding of Novitium Labs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novitium Labs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Feb 2023 | 100684380 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Novitium Labs Private Limited has 2 deals on record (2 rights issues); the latest was in March 2017.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Rights issue | ₹2.25 Cr | Investors: Novitium Pharma LLC |
| Jan 2017 | Rights issue | ₹90 Lakh | Investors: Novitium Pharma LLC |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Novitium Labs Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kancheepuram, Tamil Nadu | Criminal miscellaneous application | Filed against the company by Aic International, Represented by Its Branch Manager of Pondicherry Mr.K.Karthi | Disposed |
To see the full case history of Novitium Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Novitium Labs Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier |
To see the full MSME payment records of Novitium Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Novitium Labs Private Limited has a workforce of 163 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 163 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Novitium Labs Private Limited, buy the company report.
GST
Novitium Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCN3546C1ZU | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Novitium Labs Private Limited, buy the company report.
Recent activity
Novitium Labs Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Jayanthy Ayyavu Shanmugam ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Novitium Labs is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 September 2016 (10+ years old) and is registered under CIN U74999TN2016PTC112516.
Novitium Labs has 2 current directors:
- Ayyavu Rajavel - Director
- Shanmugam Muthusamy - Director
The latest financial statements of Novitium Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 October 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Novitium Labs is 33AAFCN3546C1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Novitium Labs is U74999TN2016PTC112516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novitium Labs has 1 court case on record: 1 filed against it.
Novitium Labs was incorporated on 15 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chennai.
Novitium Labs has 2 deals on record (2 rights issues); the latest was in March 2017.
Jayanthy Ayyavu Shanmugam ceased to be Additional Director on 30 Sep 2019. Ayyavu Rajavel was appointed as Director on 15 Sep 2016. Shanmugam Muthusamy was appointed as Director on 15 Sep 2016.
Novitium Labs has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 04 Jun 2019.
The registered office of Novitium Labs is at Module No.20 21 22 23 38&39 2nd Floor SIDCO Complex SIDCO Industrial Estate Thirumaz, Hisai, Chennai, Tamil Nadu, India – 600124.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
